Clinical Trial Results: Neuroendocrine Risk for PTSD in Women [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial investigating neuroendocrine risk factors for PTSD in women; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Snippet

Sponsor: Emory University | Conditions: PTSD, Trauma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2026-07-22